SynthesisAnatomical science international2025
Prevalence and clinical aspects of os trigonum: a meta-analysis.
Synthesis in Anatomical science international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical aspects and epidemiology of os peroneum: a meta-analysis.Anatomical science international · 2026Pooled it
- Return to Sport After Excision of Os Trigonum of Talus in Athletes.Foot & ankle orthopaedics · 2026Article
- Prevalence of the Os Supranaviculare: A Systematic Review with Meta-Analysis.Journal of clinical medicine · 2025Review
- Computed Tomography Assessment of Os Trigonum in the Omani Population and Its Clinical Relevance.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Os trigonum (OT) is one of the most common accessory ossicles in the foot and ankle region. It is believed that OT was first described by Rosenmuller in 1804, but von Bardeleben is the one who coined the nomenclature for this anatomical variation in 1883. The literature indicates that OT is extremely variable in prevalence, with reported rates ranging from 1.7% to 32.5%. In clinical practice, OT is a considerable factor that may predispose patients to posterior ankle impingement syndrome (PAIS). The aim of this study was to provide comprehensive data on the prevalence and anatomical characteristics of OT. We conducted a comprehensive search of the main electronic databases to find the relevant research. Information concerning geographical origin, prevalence, gender distribution, imaging modality, and morphometry of OT was extracted. The PRISMA guidelines were strictly followed throughout the study. The reliability of the included studies was assessed using the AQUA tool. A total of 41 studies (n = 36,612 feet) were included in this meta-analysis. This meta-analysis showed that OT was present in 9.0% (95% CI: 7.4-10.8) of the feet, and was present bilaterally in 32.7% (95% CI: 23.3-43.7) of cases. Regarding the types of imaging modality used in the evaluation of OT by the included studies, prevalence assessed by X-rays was 8.2% (95% CI: 6.8-9.9), MRI was 24.2% (95% CI: 14.6-37.3), CT was 21.0% (95% CI: 12.8-32.5), and cadaveric dissection was 5.0% (95% CI: 3.4-7.4). OT was most commonly found in East Asia (11.0%, 95% CI: 7.1-16.8). Two studies provided enough data to calculate the odds ratio linking PAIS with OT. The analysis showed that patients with PAIS are almost 16 times more likely to have OT compared to those without PAIS (OR = 15.98, 95% CI = 0.255-1002.8). OT is a very common accessory ossicle and is present in nearly one in 10 feet. The highest prevalence is noted in the East Asian population. MRI and CT show the highest prevalence of OT. It is important to keep in mind the possible presence of OT when a patient is diagnosed with PAIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.